Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Signal recognition particle 68 pseudogene 3 (SRP68P3) is a pseudogene and does not encode a functional protein. It shares sequence homology with the SRP68 gene, which encodes a protein subunit of the signal recognition particle (SRP), a ribonucleoprotein complex essential for co-translational targeting of secretory and membrane proteins to the endoplasmic reticulum. However, as a pseudogene, SRP68P3 is generally transcriptionally inactive or, if transcribed, does not produce a protein product and has no recognized biological function or therapeutic relevance[1][3]. Context and Clarification: SRP68P3 is not a functional gene or protein, and therefore not a drug target, receptor, enzyme, transporter, or transcription factor[1]. It is one of several pseudogenes of the SRP68 locus and does not participate in the canonical or noncanonical functions associated with the signal recognition particle complex; thus, it has no documented biological functions, disease relevance, or pharmacological interactions[1][3]. Information about SRP68, the functional gene, is available, but this does not apply to the pseudogene SRP68P3 except for basic sequence similarity[2][3]. Summary: SRP68P3 is a pseudogene, not a therapeutic target or biologically active molecule. There is nothing to support its role in disease, therapeutic targeting, or clinical biomarker use, and its inclusion as a target is incorrect based on current gene and protein databases[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Signal recognition particle 68 pseudogene 3 (SRP68P3).